Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146
Makker, Vicky, Taylor, Matthew H, Aghajanian, Carol, Cohn, Allen L, Brose, Marcia S, Simone, Christopher Di, Cao, Zhu Alexander, Suttner, Leah, Loboda, Andrey, Cristescu, Razvan, Jelinic, Petar, Orlowski, Robert, Dutta, Lea, Matsui, Junji, Dutcus, Corina E, Minoshima, Yukinori, Messing, Mark J
Published in Journal for immunotherapy of cancer (19.01.2024)
Published in Journal for immunotherapy of cancer (19.01.2024)
Get full text
Journal Article
Dendritic Cells in Human Thymus and Periphery Display a Proinsulin Epitope in a Transcription-Dependent, Capture-Independent Fashion
Garcia, Carlos A, Prabakar, Kamalaveni R, Diez, Juan, Cao, Zhu Alexander, Allende, Gloria, Zeller, Markus, Dogra, Rajpreet, Mendez, Armando, Rosenkranz, Eliot, Dahl, Ulf, Ricordi, Camillo, Hanahan, Douglas, Pugliese, Alberto
Published in The Journal of immunology (1950) (15.08.2005)
Published in The Journal of immunology (1950) (15.08.2005)
Get full text
Journal Article
COMBINATION THERAPIES
RONG XIANHUI, LEE BENJAMIN HYUN, LONGMIRE TYLER, PINZON ORTIZ MARIA CONSUELO, CAO ZHU ALEXANDER
Year of Publication 14.06.2017
Get full text
Year of Publication 14.06.2017
Patent
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Chung, Hyun Cheol, Bang, Yung-Jue, S Fuchs, Charles, Qin, Shu-Kui, Satoh, Taroh, Shitara, Kohei, Tabernero, Josep, Van Cutsem, Eric, Alsina, Maria, Cao, Zhu Alexander, Lu, Jia, Bhagia, Pooja, Shih, Chie-Schin, Janjigian, Yelena Y
Published in Future oncology (London, England) (01.02.2021)
Published in Future oncology (London, England) (01.02.2021)
Get full text
Journal Article
PIM KINASE INHIBITOR COMBINATIONS
VANASSE K. GARY J, SACI ABDEL, GROWNEY JOSEPH DANIEL, CAO ZHU ALEXANDER
Year of Publication 12.04.2016
Get full text
Year of Publication 12.04.2016
Patent
COMBINATION THERAPY OF A MEK INHIBITOR AND IGF1R INHIBITOR
PETERS MALTE, CHANG DAVID DONG EUN, HUANG XIZHONG, BELTRAN PEDRO, CAO ZHU ALEXANDER, GANSERT JENNIFER LORRAINE
Year of Publication 24.12.2014
Get full text
Year of Publication 24.12.2014
Patent
COMBINATION THERAPY
LI FANG, MONAHAN JOHN, LIANG JINSHENG, SHENG QING, WANG HUI QIN, CAO ZHU ALEXANDER, VERSACE RICHARD
Year of Publication 13.07.2015
Get full text
Year of Publication 13.07.2015
Patent
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer
Shah, Manish A, Kojima, Takashi, Hochhauser, Daniel, Enzinger, Peter, Raimbourg, Judith, Hollebecque, Antoine, Lordick, Florian, Kim, Sung-Bae, Tajika, Masahiro, Lockhart, Albert Craig, Arkenau, Hendrick-Tobias, El-Hajbi, Farid, Gupta, Mukul, Pfeiffer, Per, Bhagia, Pooja, Cao, Zhu Alexander, Lunceford, Jared, Suryawanshi, Shailaja, Ayers, Mark, J Marton, Matthew, Kato, Ken
Published in Future oncology (London, England) (01.08.2022)
Published in Future oncology (London, England) (01.08.2022)
Get full text
Journal Article
Abstract 1314: Evaluation of PD-L1 mRNA and protein expression in non-small cell lung and hepatocellular carcinoma
Jaeger, Savina, Lee, Benjamin H., Mosher, Rebecca, Shebnova, Olga, Wang, Yan, Yu, Yenyen, Yang, David, Murakami, Masato, Greshock, Joel, Schlegel, Robert, Boral, Anthony, Cao, Zhu Alexander
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article